Guan Jiang
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Genetics top 5%
- Glioma Diagnosis and Treatment
Papers in
- Co-authors
- Liantao LiQian ChenJun ZhengXiaoyang HouJunnian ZhengYan LiuXinxin LiChunsheng Yang
- Journals
- Cancer Medicine (3 papers)Anti-Cancer Agents in Medicinal Chemistry (3 papers)Cancer Letters (2 papers)International Journal of Cancer (2 papers)Molecular Biology Reports (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Guan Jiang
50 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Cancer Research 275
- Genetics 163
- Biomaterials 167
- Oncology 339
- Molecular Biology 804
Countries citing papers authored by Guan Jiang
This map shows the geographic impact of Guan Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guan Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guan Jiang more than expected).
Fields of papers citing papers by Guan Jiang
This network shows the impact of papers produced by Guan Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guan Jiang. The network helps show where Guan Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Guan Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 16 | |
| 3 | 2024 | 11 | |
| 4 | 2023 | 28 | |
| 5 | 2023 | 9 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 3 | |
| 8 | 2018 | 194 | |
| 9 | 2018 | 33 | |
| 10 | 2017 | 61 | |
| 11 | 2017 | 4 | |
| 12 | Thalidomide for Control Delayed Vomiting in Cancer Patients Receiving Chemotherapy. | 2016 | 2 |
| 13 | 2016 | 17 | |
| 14 | 2016 | 19 | |
| 15 | 2015 | 6 | |
| 16 | Temozolomide for Treating Malignant Melanoma. | 2015 | 25 |
| 17 | 2014 | 17 | |
| 18 | 2014 | 48 | |
| 19 | 2013 | 12 | |
| 20 | 2012 | 18 |
About Guan Jiang
Guan Jiang is a scholar working on Oncology, Genetics, Biophysics, Dermatology and Molecular Biology, having authored 52 papers that have together received 2.0k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (11 papers), CAR-T cell therapy research (5 papers), Virus-based gene therapy research (4 papers), RNA Interference and Gene Delivery (4 papers), Immunotherapy and Immune Responses (4 papers), Cutaneous Melanoma Detection and Management (4 papers), Photodynamic Therapy Research Studies (4 papers) and Glioma Diagnosis and Treatment (3 papers). The work is most often cited by research in Cancer Research (275 citations), Genetics (163 citations), Biomaterials (167 citations), Oncology (339 citations) and Molecular Biology (804 citations). Guan Jiang has collaborated with scholars based in China and United States. Frequent co-authors include Liantao Li, Qian Chen, Jun Zheng, Xiaoyang Hou, Junnian Zheng, Yan Liu, Xinxin Li, Chunsheng Yang, Hua Cao and Lei Chen. Their work appears in journals such as Cancer Medicine, Anti-Cancer Agents in Medicinal Chemistry, Cancer Letters, International Journal of Cancer and Molecular Biology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.